Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Inhalable Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Inhalable Drugsmarket, defines the market attractiveness level of Inhalable Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Inhalable Drugs industry, describes the types of Inhalable Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Inhalable Drugs market and the development prospects and opportunities of Inhalable Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Inhalable Drugs market in Chapter 13.
By Player:
NanoDerma
Aradigm Corporation
Pfizer
AeroGen and Inhale Therapeutic Systems
Alkerme
Dura Pharmaceuticals
By Type:
Suspension Aerosol
Solution Aerosol
Dry Powder Formulation
By End-User:
Respiratory diseases
Non-respiratory diseases
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Inhalable Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Inhalable Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Inhalable Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Inhalable Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Inhalable Drugs Market Analysis and Outlook to 2022
-
7.1 Global Inhalable Drugs Consumption (2017-2022)
-
7.2 United States Inhalable Drugs Consumption (2017-2022)
-
7.3 Europe Inhalable Drugs Consumption (2017-2022)
-
7.4 China Inhalable Drugs Consumption (2017-2022)
-
7.5 Japan Inhalable Drugs Consumption (2017-2022)
-
7.6 India Inhalable Drugs Consumption (2017-2022)
-
7.7 South Korea Inhalable Drugs Consumption (2017-2022)
8 Region and Country-wise Inhalable Drugs Market Analysis and Outlook to 2028
-
8.1 Global Inhalable Drugs Consumption Forecast (2022-2028)
-
8.2 United States Inhalable Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Inhalable Drugs Consumption Forecast (2022-2028)
-
8.4 China Inhalable Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Inhalable Drugs Consumption Forecast (2022-2028)
-
8.6 India Inhalable Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Inhalable Drugs Consumption Forecast (2022-2028)
9 Global Inhalable Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Inhalable Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Suspension Aerosol Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Solution Aerosol Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dry Powder Formulation Consumption and Growth Rate (2017-2022)
-
9.2 Global Inhalable Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Respiratory diseases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Non-respiratory diseases Consumption and Growth Rate (2017-2022)
10 Global Inhalable Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Inhalable Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Suspension Aerosol Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Solution Aerosol Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Dry Powder Formulation Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Inhalable Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Respiratory diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Non-respiratory diseases Consumption Forecast and Growth Rate (2022-2028)
11 Global Inhalable Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Inhalable Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Inhalable Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Inhalable Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Inhalable Drugs Market Competitive Analysis
-
14.1 NanoDerma
-
14.1.1 NanoDerma Company Details
-
14.1.2 NanoDerma Inhalable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 NanoDerma Inhalable Drugs Product and Service
-
14.2 Aradigm Corporation
-
14.2.1 Aradigm Corporation Company Details
-
14.2.2 Aradigm Corporation Inhalable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Aradigm Corporation Inhalable Drugs Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Inhalable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Inhalable Drugs Product and Service
-
14.4 AeroGen and Inhale Therapeutic Systems
-
14.4.1 AeroGen and Inhale Therapeutic Systems Company Details
-
14.4.2 AeroGen and Inhale Therapeutic Systems Inhalable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AeroGen and Inhale Therapeutic Systems Inhalable Drugs Product and Service
-
14.5 Alkerme
-
14.5.1 Alkerme Company Details
-
14.5.2 Alkerme Inhalable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Alkerme Inhalable Drugs Product and Service
-
14.6 Dura Pharmaceuticals
-
14.6.1 Dura Pharmaceuticals Company Details
-
14.6.2 Dura Pharmaceuticals Inhalable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Dura Pharmaceuticals Inhalable Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Inhalable Drugs
-
Figure Inhalable Drugs Picture
-
Table Global Inhalable Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Inhalable Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Inhalable Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Inhalable Drugs Consumption by Country (2017-2022)
-
Figure United States Inhalable Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Inhalable Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Inhalable Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Inhalable Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Inhalable Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Inhalable Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Inhalable Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Inhalable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Inhalable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Inhalable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Inhalable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Inhalable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Inhalable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Suspension Aerosol Consumption and Growth Rate (2017-2022)
-
Figure Global Solution Aerosol Consumption and Growth Rate (2017-2022)
-
Figure Global Dry Powder Formulation Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Non-respiratory diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Suspension Aerosol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solution Aerosol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dry Powder Formulation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-respiratory diseases Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Inhalable Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Inhalable Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table NanoDerma (Foundation Year, Company Profile and etc.)
-
Table NanoDerma Inhalable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table NanoDerma Inhalable Drugs Product and Service
-
Table Aradigm Corporation (Foundation Year, Company Profile and etc.)
-
Table Aradigm Corporation Inhalable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aradigm Corporation Inhalable Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inhalable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inhalable Drugs Product and Service
-
Table AeroGen and Inhale Therapeutic Systems (Foundation Year, Company Profile and etc.)
-
Table AeroGen and Inhale Therapeutic Systems Inhalable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AeroGen and Inhale Therapeutic Systems Inhalable Drugs Product and Service
-
Table Alkerme (Foundation Year, Company Profile and etc.)
-
Table Alkerme Inhalable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkerme Inhalable Drugs Product and Service
-
Table Dura Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Dura Pharmaceuticals Inhalable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dura Pharmaceuticals Inhalable Drugs Product and Service
-
